Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Artif Intell Gastrointest Endosc. Aug 28, 2021; 2(4): 95-102
Published online Aug 28, 2021. doi: 10.37126/aige.v2.i4.95
Published online Aug 28, 2021. doi: 10.37126/aige.v2.i4.95
Artificial intelligence assisted assessment of endoscopic disease activity in inflammatory bowel disease
Bobby Lo, Johan Burisch, Gastrounit, Medical Section, Copenhagen University Hospital Hvidovre, Hvidovre 2650, Denmark
Bobby Lo, Johan Burisch, Copenhagen Centre for Inflammatory Bowel Disease in Children, Adolescents and Adults, Copenhagen University Hospital Hvidovre, Hvidovre 2650, Denmark
Author contributions: Lo B and Burisch J authors have made a significant contribution to the research described in this manuscript; all authors approved the final manuscript as well as the authorship list.
Conflict-of-interest statement: Lo B has received a lecture fee from Janssen-Cilag; Burisch J has received consulting fees from Celgene, Janssen-Cilag, AbbVie, Vifor Pharma, Jansen and Ferring; lecture fees from Abbvie, Pfizer, MSD, Pharmacosmos and Takeda Pharma, and unrestricted grant support from Takeda Pharma and Tillotts Pharma.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Bobby Lo, MD, Doctor, Gastrounit, Medical Section, Copenhagen University Hospital Hvidovre, Kettegård Alle 30, Hvidovre 2650, Denmark.
Received: April 28, 2021
Peer-review started: April 28, 2021
First decision: June 13, 2021
Revised: June 27, 2021
Accepted: August 16, 2021
Article in press: August 16, 2021
Published online: August 28, 2021
Processing time: 130 Days and 13.4 Hours
Peer-review started: April 28, 2021
First decision: June 13, 2021
Revised: June 27, 2021
Accepted: August 16, 2021
Article in press: August 16, 2021
Published online: August 28, 2021
Processing time: 130 Days and 13.4 Hours
Core Tip
Core Tip: Artificial intelligence (AI) is on the rise in inflammatory bowel diseases (IBD). Endoscopic evaluation is so far the most studied modality with promising results. Studies with others or the combination of several modalities have been carried out with moderate results leaving room for future research. Data availability and standardisation of the reporting of these new models seem to be the biggest challenges for AI's breakthrough within IBD. International consensus in the field is required to optimise research in AI.